RIM
LMAT icon

Ranger Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Ranger Investment Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26M Sell
238,360
-138,672
-37% -$13.2M 1.88% 16
2025
Q4 		$30.6M Sell
377,032
-8,768
-2% -$755K 2.1% 10
2025
Q3 		$33.8M Sell
385,800
-128,274
-25% -$11.5M 2.35% 6
2025
Q2 		$42.7M Sell
514,074
-8,435
-2% -$705K 2.98% 5
2025
Q1 		$43.8M Sell
522,509
-135,720
-21% -$12.6M 3.13% 4
2024
Q4 		$60.6M Sell
658,229
-27,226
-4% -$2.62M 3.83% 2
2024
Q3 		$63.7M Sell
685,455
-128,458
-16% -$11.1M 4.09% 1
2024
Q2 		$67M Sell
813,913
-9,800
-1% -$720K 4.56% 1
2024
Q1 		$54.7M Sell
823,713
-88,790
-10% -$5.48M 3.52% 2
2023
Q4 		$51.8M Buy
912,503
+13,681
+2% +$717K 3.14% 2
2023
Q3 		$49M Buy
898,822
+122,601
+16% +$7.27M 3.25% 3
2023
Q2 		$52.2M Sell
776,221
-213,764
-22% -$13M 3.14% 2
2023
Q1 		$51M Buy
989,985
+41,505
+4% +$2.01M 3.41% 4
2022
Q4 		$43.6M Buy
948,480
+25,878
+3% +$1.21M 3.24% 5
2022
Q3 		$46.8M Buy
922,602
+27,143
+3% +$1.36M 3.67% 3
2022
Q2 		$40.8M Buy
895,459
+225,033
+34% +$10.1M 3.09% 8
2022
Q1 		$31.2M Buy
670,426
+23,427
+4% +$1.05M 1.97% 20
2021
Q4 		$32.5M Buy
646,999
+10,010
+2% +$518K 1.77% 23
2021
Q3 		$33.8M Buy
636,989
+143,235
+29% +$8.07M 1.8% 22
2021
Q2 		$30.1M Sell
493,754
-9,666
-2% -$513K 1.57% 29
2021
Q1 		$24.6M Sell
503,420
-53,525
-10% -$2.51M 1.35% 37
2020
Q4 		$22.6M Sell
556,945
-190,086
-25% -$6.79M 1.19% 38
2020
Q3 		$24.3M Buy
747,031
+90,364
+14% +$2.71M 1.55% 28
2020
Q2 		$17.3M Sell
656,667
-166,528
-20% -$4.35M 1.19% 38
2020
Q1 		$20.5M Sell
823,195
-53,171
-6% -$1.64M 1.8% 23
2019
Q4 		$31.5M Buy
876,366
+268,834
+44% +$9.28M 2.08% 17
2019
Q3 		$20.8M Sell
607,532
-13,125
-2% -$419K 1.49% 35
2019
Q2 		$17.4M Buy
620,657
+585
+0.1% +$16.3K 1.18% 39
2019
Q1 		$19.2M Sell
620,072
-112,308
-15% -$3M 1.39% 37
2018
Q4 		$17.3M Buy
732,380
+9,688
+1% +$265K 1.41% 32
2018
Q3 		$28M Buy
722,692
+22,849
+3% +$823K 1.85% 27
2018
Q2 		$23.4M Buy
699,843
+309,204
+79% +$11M 1.64% 29
2018
Q1 		$14.2M Buy
390,639
+7,000
+2% +$242K 1.05% 42
2017
Q4 		$12.2M Sell
383,639
-13,580
-3% -$465K 0.9% 44
2017
Q3 		$14.9M Buy
397,219
+359,643
+957% +$12.2M 1.11% 41
2017
Q2 		$1.17M Buy
+37,576
New +$1.09M 0.08% 79

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Ranger Investment Management's LMAT Position: Q1 2026 in Review

Ranger Investment Management reduced its LeMaitre Vascular (LMAT) stake by 37% in Q1 2026, selling an estimated $13.2M and leaving 238,360 shares worth $26M. The position accounts for 1.88% of the portfolio, ranked #16.

Ranger Investment Management first reported a position in LMAT in Q2 2017 and has held it in 36 quarters since. The position peaked at $67M in Q2 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Ranger Investment Management held 238,360 shares of LeMaitre Vascular worth $26M as of Q1 2026.
  • Ranger Investment Management sold 138,672 LeMaitre Vascular shares in Q1 2026, an estimated $13.2M.
  • LeMaitre Vascular made up 1.88% of Ranger Investment Management's portfolio in Q1 2026, its #16 holding.
  • Ranger Investment Management first reported a position in LeMaitre Vascular in Q2 2017 and has held it in 36 quarters since.
  • Ranger Investment Management's LeMaitre Vascular position peaked at $67M in Q2 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Ranger Investment Management's 13F filing for Q1 2026, filed 15 May 2026.